1. Identification of and surveillance for the SARS-CoV-2 variants B.1.427 and B.1.429—Colorado, January–March 2021.;Martin Webb;MMWR Morb Mortal Wkly Rep,2021
2. Turner K, Davidson SL, Collins J, Update to the standardized surveillance case definition and national notification for 2019 novel coronavirus disease (COVID-19). Atlanta, GA: Council of State and Territorial Epidemiologists; 2020. https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-02_COVID-19.pdf
3. CDC. COVID-19 vaccine breakthrough case investigation and reporting. Atlanta, GA: US Department of Health and Human Services, CDC: 2021. Accessed July 1, 2021. https://www.cdc.gov/vaccines/covid-19/health-departments/breakthrough-cases.html
4. World Health Organization. Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: interim guidance, 22 July 2021: addendum to evaluation of COVID-19 vaccine effectiveness, 2021. Geneva, Switzerland: World Health Organization; 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-variants-2021.1
5. Public Health England. SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 17. London, United Kingdom: Public Health England; 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001354/Variants_of_Concern_VOC_Technical_Briefing_17.pdf